Trial
NCT02952586
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Pfizer
Collaborators
—
Condition
Squamous Cell Carcinoma of the Head and Neck
Intervention
Avelumab
Why stopped
The trial prematurely terminated as recommended by the E-DMC because the boundary for futility has been crossed.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-09-22